HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer

BACKGROUND: Metastatic breast cancer (mBC) causes nearly all BC-related deaths. Next-generation sequencing (NGS) technologies allow for the application of personalized medicine using targeted therapies that could improve patients’ outcomes. However, NGS is not routinely used in the clinical practice...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivera-Salguero, Rubén, Seguí, Elia, Cejalvo, Juan Miguel, Oliveira, Mafalda, Tolosa, Pablo, Vidal, Maria, Malumbres, Marcos, Gavilá, Joaquín, Saura, Cristina, Pernas, Sonia, López, Rafael, Margelí, Mireia, Balmaña, Judith, Muñoz, Montserrat, Blancas, Isabel, Boni, Valentina, Ciruelos, Eva, Galve, Elena, Perelló, Antonia, Sánchez-Bayona, Rodrigo, de la Cruz, Susana, de la Hoya, Miguel, Galván, Patricia, Sanfeliu, Esther, Gonzalez-Farre, Blanca, Sirenko, Valeria, Blanch-Torras, Aura, Canes, Jordi, Masanas, Helena, Olmos, Rosa, Forns, Margarita, Prat, Aleix, Casas, Ana, Pascual, Tomás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175800/
https://www.ncbi.nlm.nih.gov/pubmed/37188177
http://dx.doi.org/10.3389/fonc.2023.1151496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175800/
https://www.ncbi.nlm.nih.gov/pubmed/37188177
http://dx.doi.org/10.3389/fonc.2023.1151496

Ejemplares similares